Press "Enter" to skip to content

StarMed Healthcare to Open Site Dedicated to COVID-19 Care in Cumberland County

Spread the love

StarMed will offer testing, vaccinations, and monoclonal antibody therapy treatments in response to demand Cumberland County, NC (November 9, 2021) – StarMed Healthcare is set to open a location in Cumberland County that will offer the entire range of COVID-19 care, including vaccinations, testing and administering doses of COVID- 19 antibody therapy to meet the demand of patients seeking care.

The site is scheduled to open in mid-November. The company has signed a lease at 6917 Raeford Rd. in Fayetteville, N.C. to open appointment slots that are needed in the area, through a partnership with the State of North Carolina. Operating hours will be Monday-Friday from 9 a.m. to 4 p.m. StarMed has and will continue to work with other counties around the state to set up similar clinics.

VACCINES: StarMed’s Fayetteville location will offer the Pfizer, Moderna and Johnson & Johnson vaccines. Vaccinations are proven to be safe and effective. The vaccinations are free, with or without insurance.

TESTING: Patients of all ages can be tested for COVID-19. There is no cost. No referrals are necessary, and walk-up patients are welcome. A StarMed medical technician will gently collect a nasal swab sample. You can get instant results with a rapid test, or a PCR test that will provide your results in a day or so, by email and text message.

ANTIBODY THERAPY: StarMed is administering doses of COVID-19 monoclonal antibody therapy. If you’re a patient with mild to moderate COVID-19 symptoms, research shows that antibody therapy can reduce the length and severity of the symptoms and lessen your chance of hospitalization. Monoclonal antibody therapy, available to patients ages 12 and older, is free. The therapy is not a substitute for getting the COVID-19 vaccine. The antibodies are administered through either a 21-minute IV infusion or subcutaneous injection, followed by a 60-minute observation for any side effects. Minor side effects include nausea and dizziness, while serious side effects are rare.

StarMed’s goal is to relieve the burden on the hospital system by offering COVID-19 antibody therapy to patients, which research validation has shown:

● Reduces the mortality rate of COVID-19 by 20%-70%.
● Decreases symptoms in COVID-positive patients by two weeks.
● Decreases viral loads to make patients less contagious.
Patients who SHOULD receive doses of COVID-19 antibody therapy:
● Individuals ages 12 and older who are unvaccinated can receive monoclonal antibody therapy.
● Anyone who is vaccinated but has an immunocompromised state due to underlying health conditions like
cancer, organ transplants, autoimmune disorders, or chronic steroid use.
● Individuals who are positive with COVID-19 with mild or moderate symptoms.
Patients who SHOULD NOT receive doses of COVID-19 antibody therapy:
● Patients with severe symptoms, and anyone who is requiring increased oxygen due to being positive with
COVID-19.
● Anyone who is exposed to COVID-19 but has been vaccinated and can mount a good response.

StarMed Healthcare is valued on accessible modern facilities, trusted and professional healthcare, and diversity and affordability. It offers community-focused, fully equipped urgent care centers and family medicine practice.